(NP (NP (NN Background)) (: :) (S (NP (NP (NP (DT An) (VBG increasing) (NN volume)) (PP (IN of) (NP (NN prostate) (NNS biopsies)))) (CC and) (NP (NP (DT a) (JJ world-wide) (NN shortage)) (PP (IN of) (NP (NNS uro-pathologists))))) (VP (VBZ puts) (NP (DT a) (NN strain)) (PP (IN on) (NP (NN pathology) (NNS departments))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (NP (DT the) (JJ high) (ADJP (JJ intra-) (CC and) (JJ inter-observer)) (NN variability)) (PP (IN in) (NP (VBG grading)))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (JJ over-) (CC and) (JJ undertreatment)) (PP (IN of) (NP (NN prostate) (NN cancer))))))) (. .))
(S (NP (JJ Artificial) (NN intelligence) (PRN (-LRB- -LRB-) (NNP AI) (-RRB- -RRB-)) (NNS methods)) (VP (MD may) (VP (VB alleviate) (NP (DT these) (NNS problems)) (PP (IN by) (S (VP (VBG assisting) (S (NP (NNS pathologists)) (VP (TO to) (VP (VP (VB reduce) (NP (NN workload))) (CC and) (VP (VB harmonize) (NP (NN grading))))))))))) (. .))
(NP (NP (NNS Methods)) (: :) (S (NP (PRP We)) (VP (VBD digitized) (NP (NP (CD 6,682) (JJ needle) (NNS biopsies)) (PP (IN from) (NP (NP (CD 976) (NNS participants)) (PP (IN in) (NP (DT the) (ADJP (NN population) (VBN based)) (NNP STHLM3) (JJ diagnostic) (NN study)))))) (S (VP (TO to) (VP (VB train) (NP (JJ deep) (JJ neural) (NNS networks)) (PP (IN for) (S (VP (VBG assessing) (NP (JJ prostate) (NNS biopsies)))))))))) (. .))
(S (NP (DT The) (NNS networks)) (VP (VBD were) (VP (VBN evaluated) (PP (IN by) (S (VP (VBG predicting) (NP (NP (DT the) (NX (NX (NN presence)) (, ,) (NX (NN extent)) (, ,) (CC and) (NX (NNP Gleason) (NN grade)))) (PP (IN of) (NP (JJ malignant) (NN tissue)))) (PP (IN for) (NP (NP (DT an) (JJ independent) (NN test) (VBN set)) (VP (VBG comprising) (NP (NP (CD 1,631) (NNS biopsies)) (PP (IN from) (NP (CD 245) (NNS men)))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB additionally)) (VP (VBD evaluated) (NP (NP (VBG grading) (NN performance)) (PP (IN on) (NP (NP (CD 87) (NNS biopsies)) (VP (ADVP (RB individually)) (VBN graded) (PP (IN by) (NP (NP (CD 23) (JJ experienced) (JJ urological) (NNS pathologists)) (PP (IN from) (NP (NP (DT the) (NNP International) (NNP Society)) (PP (IN of) (NP (NNP Urological) (NNP Pathology)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD assessed) (NP (NP (JJ discriminatory) (NN performance)) (PP (IN by) (NP (NP (NP (NN receiver) (NN operating) (NNS characteristics)) (PRN (-LRB- -LRB-) (NP (NNP ROC)) (-RRB- -RRB-))) (CC and) (NP ($ tumor) (JJ extent) (NNS predictions))))) (PP (IN by) (S (VP (VBG correlating) (NP (VBN predicted) (NN millimeter) (NN cancer) (NN length)) (PP (IN against) (NP (NP (NNS measurements)) (PP (IN by) (NP (DT the) (NN reporting) (NN pathologist))))))))) (. .))
(S (NP (PRP We)) (VP (VBD quantified) (NP (NP (DT the) (NN concordance)) (PP (IN between) (NP (NP (NNS grades)) (VP (VBN assigned) (PP (IN by) (NP (NP (DT the) (NNP AI)) (CC and) (NP (NP (DT the) (JJ expert) (JJ urological) (NNS pathologists)) (VP (VBG using) (NP (NP (NNP Cohen) (POS 's)) (NN kappa))))))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (NNP AI))) (S (VP (TO to) (VP (VB detect) (CC and) (VB grade) (NP (NN cancer)) (PP (IN in) (NP (NN prostate) (JJ needle) (NN biopsy) (NNS samples))))))) (VP (VBD was) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ international) (NNS experts)) (PP (IN in) (NP (NN prostate) (NN pathology)))))))))) (. .))
(S (NP (DT The) (NNP AI)) (VP (VBD achieved) (NP (NP (DT an) (NN area)) (PP (IN under) (NP (DT the) (NNP ROC) (NN curve))) (PP (IN of) (NP (NP (NP (CD 0.997)) (PP (IN for) (S (VP (VBG distinguishing) (PP (IN between) (NP (NN benign) (CC and) (JJ malignant) (NN biopsy) (NNS cores))))))) (, ,) (CC and) (NP (NP (CD 0.999)) (PP (IN for) (S (VP (VBG distinguishing) (PP (IN between) (NP (NP (NNS men)) (PP (IN with) (CC or) (IN without) (NP (JJ prostate) (NN cancer))))))))))))) (. .))
(S (NP (NP (DT The) (NN correlation)) (PP (IN between) (NP (NP (NN millimeter) (NN cancer)) (VP (VP (VBN predicted) (PP (IN by) (NP (DT the) (NNP AI)))) (CC and) (VP (VBN assigned) (PP (IN by) (NP (DT the) (NN reporting) (NN pathologist)))))))) (VP (VBD was) (NP (CD 0.96))) (. .))
(S (PP (IN For) (S (VP (VBG assigning) (NP (NNP Gleason) (NNS grades))))) (, ,) (NP (DT the) (NNP AI)) (VP (VBD achieved) (NP (NP (DT an) (JJ average) (NN pairwise) (NN kappa)) (PP (IN of) (NP (CD 0.62))))) (. .))
(S (NP (DT This)) (VP (VBD was) (PP (IN within) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (NP (DT the) (JJ corresponding) (NNS values)) (PP (IN for) (NP (DT the) (JJ expert) (NNS pathologists)))) (PRN (-LRB- -LRB-) (NP (QP (CD 0.60) (TO to) (CD 0.73))) (-RRB- -RRB-))))))) (. .))
